- Green Cross Health unveils an impressive half-year performance, with its revenue up by 12% to NZ$310 million.
- It would reward its shareholders with an interim dividend payable next month.
It would reward its shareholders with an interim dividend payable next month.
Green Cross Health Limited (NZX:GXH) has published its half-year results.
It is noted that the Company is a primary healthcare provider, operating 351 Unichem and Life Pharmacies throughout the country and has over 42,000 community health clients.
Source: Copyright © 2021 Kalkine Media
All the three divisions of GXH noted solid growth
Green Cross Health showcased a solid half-year performance with 12% growth in its revenue, amounting to NZ$310 million, for the period ended 30 September 2021.
Further, its EBIT was reported at NZ$20.5 million, and its NPAT clocked NZ$9.7 million, up 14% and 9%, respectively, underpinned by an increase in activity across all its three divisions, namely, pharmacies, medical centres and community health services.
GXH has announced 3.0 cps as its interim dividend, payable on 22 December.
It is pointed out that at the New Zealand Primary Healthcare awards, organised early this year, all its three divisions secured the top position.
Moreover, the Company is focusing on its acquisitive growth, thereby adding four medical centres and two pharmacies to its list and has also invested in a digital health company.
At the time of writing, Green Cross Health was trading up by 5.22% at NZ$1.210, on 26 November.
Boasting a robust balance sheet and strong business performance, the healthcare provider maintains a positive outlook for the year ahead, supporting further acquisitions and enhanced dividends.